CACCIARI, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 209
EU - Europa 85
AS - Asia 31
AF - Africa 2
Totale 327
Nazione #
US - Stati Uniti d'America 207
IT - Italia 37
SE - Svezia 28
CN - Cina 8
PL - Polonia 8
VN - Vietnam 6
DE - Germania 5
YE - Yemen 5
ID - Indonesia 3
IN - India 3
CA - Canada 2
CZ - Repubblica Ceca 2
EG - Egitto 2
BG - Bulgaria 1
IE - Irlanda 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
RO - Romania 1
RU - Federazione Russa 1
SG - Singapore 1
TW - Taiwan 1
UA - Ucraina 1
Totale 327
Città #
Santa Cruz 32
Stockholm 28
Fairfield 18
Houston 14
Ferrara 11
Ann Arbor 9
Buffalo 8
Warsaw 8
Ashburn 7
Des Moines 7
Seattle 7
Cambridge 6
Dong Ket 6
Wilmington 6
Sanaa 5
Trieste 5
Chicago 4
Las Vegas 4
Nashville 4
Caravaggio 3
Ferrara di Monte Baldo 3
Fleming Island 3
Shanghai 3
Woodbridge 3
Cairo 2
Cheyenne 2
Clearwater 2
Feasterville Trevose 2
Jakarta 2
Lake Forest 2
Norwalk 2
Provo 2
Andover 1
Beijing 1
Bengaluru 1
Cagliari 1
Columbus 1
Como 1
Denver 1
Dublin 1
Falkenstein 1
Frankfurt Am Main 1
Guangzhou 1
Henderson 1
Herndon 1
Jerusalem 1
Kashan 1
Kiev 1
Lombard 1
Mountain View 1
New York 1
Padang 1
Palo del Colle 1
Pettorazza Grimani 1
Providence 1
Rende 1
Rochester 1
Saint Petersburg 1
San Diego 1
San Francisco 1
Scranton 1
Sofia 1
Taipei 1
Toronto 1
Totale 252
Nome #
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists, file e309ade3-8cf0-3969-e053-3a05fe0a2c94 145
Structure Activity Relationship of 4-Amino-2-thiopyrimidine Derivatives as Platelet Aggregation Inhibitors, file e309ade3-9706-3969-e053-3a05fe0a2c94 57
Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach, file e309ade1-e366-3969-e053-3a05fe0a2c94 51
The influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl moiety on the adenosine receptors affinity profile of pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c] pyrimidine derivatives, file e309ade3-9204-3969-e053-3a05fe0a2c94 39
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones, file e309ade2-e2ab-3969-e053-3a05fe0a2c94 14
Synthesis and biological evaluation of new antitubulin agents containing 2-(30,40,50-trimethoxyanilino)-3,6-disubstituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine Scaffold, file e309ade2-9b91-3969-e053-3a05fe0a2c94 9
5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors, file e309ade3-9753-3969-e053-3a05fe0a2c94 8
Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents, file e309ade5-675e-3969-e053-3a05fe0a2c94 4
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors, file e309ade0-2a46-3969-e053-3a05fe0a2c94 2
Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites., file e309ade0-3b2f-3969-e053-3a05fe0a2c94 2
null, file e309ade0-b09c-3969-e053-3a05fe0a2c94 2
null, file e309ade0-a086-3969-e053-3a05fe0a2c94 1
5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors, file e309ade0-c262-3969-e053-3a05fe0a2c94 1
null, file e309ade2-2d80-3969-e053-3a05fe0a2c94 1
Totale 336
Categoria #
all - tutte 781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 781


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0000 00 00 0100
2020/202151 0000 00 12 1115157
2021/2022163 914424 165 910 7153416
2022/2023115 35345 515 1020 18000
Totale 336